S

Santhera Pharmaceuticals

69 employees

Santhera Pharmaceuticals develops and markets pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
Pharmaceutical

Date founded

2004

Funding rounds raised

Total raised

$27M

from 14 investors over 14 rounds

S

Santhera Pharmaceuticals raised $5.4M on January 10, 2023

Investors: Idorsia Pharmaceuticals Ltd

S

Santhera Pharmaceuticals raised $27M on September 20, 2021

Investors: Highbridge Capital Management

S

Santhera Pharmaceuticals raised $24M on September 20, 2021

Investors: Waypoint Capital, Idorsia Pharmaceuticals Ltd and Highbridge Capital Management

S

Santhera Pharmaceuticals raised $21M on June 4, 2020

Investors: Highbridge Capital Management

S

Santhera Pharmaceuticals raised $19M on October 5, 2006

Investors: Carnegie Asset Management, Gimv, BioMedPartners and 3i Group plc

S

Santhera Pharmaceuticals raised $19M on December 20, 2005

Investors: Gimv, Carnegie Asset Management, 3i Group plc and Heidelberg Innovation

FAQ